Hyundai introduces upgraded online retail platform 'Click to Buy'

The company, which had launched the platform in March, has invested around $1 million (around Rs 7.5 crore) to develop it to offer customer services from booking of cars to test drive to financing and delivery at home.

PTI

June 03, 2020 / 16:53 IST

Hyundai Motor India Ltd (HMIL) on Wednesday introduced its upgraded online end-to-end automotive retail platform 'Click to Buy' curated to provide future retail experience to customers in the wake of COVID-19 pandemic.

The company, which had launched the platform in March, has invested around $1 million (around Rs 7.5 crore) to develop it to offer customer services from booking of cars to test drive to financing and delivery at home.

Addressing media through a video-conference, HMIL Executive Director – Corporate Planning W S Oh said, "Since the launch of Click to Buy, we have received over 7 lakh visitors on the platform and have recorded over 15,000 registrations in two months.”

Through the platform, the company has now integrated all of its over 600 dealerships, providing them another additional channel to draw customers and sell cars, he added.

The company claimed that 'Click to Buy' will become the 'new normal' for buying car by providing a one-stop solution for customers' car ownership requirement.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show